UNH executive granted 89.629 dividend-equivalent shares

UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards.

Rhea-AI Filing Summary

UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.

The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.

Insider Trade Summary

Grant/Award: 89.629 shares

Grant/Award 1 txn

Insider Zaetta Christopher R

Role EVP & Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	89.629	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,716.169 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UNITEDHEALTH GROUP INC (UNH) report for Christopher R. Zaetta?

UNITEDHEALTH GROUP INC reported that EVP & Chief Legal Officer Christopher R. Zaetta acquired 89.629 shares of Common Stock as a grant or award. This was recorded on March 17, 2026 and reflects compensation-related equity rather than an open-market stock purchase.

How many UNITEDHEALTH GROUP INC (UNH) shares does Christopher R. Zaetta hold after this Form 4?

After the reported transaction, Christopher R. Zaetta directly holds 16,716.169 shares of UNITEDHEALTH GROUP INC Common Stock. This total includes the 89.629 shares acquired through the grant or award reported on March 17, 2026 in this Form 4 filing.

What is the nature of the 89.629 UNH shares reported for Christopher R. Zaetta?

The 89.629 shares represent dividend equivalents paid on outstanding restricted stock units held by Christopher R. Zaetta. These dividend equivalents are subject to the same vesting terms as the related restricted stock units and will be forfeited if those units ultimately fail to vest.

Did Christopher R. Zaetta buy UNITEDHEALTH GROUP INC (UNH) stock in the open market?

No, the filing shows a grant or award acquisition at a stated price of $0.00 per share, not an open-market purchase. The shares represent dividend equivalents on restricted stock units, tied to existing equity awards and subject to vesting conditions rather than a cash transaction.

Are the dividend equivalent shares for UNH fully vested for Christopher R. Zaetta?

The dividend equivalent shares are not automatically fully vested. The footnote states they are subject to the same terms as the underlying restricted stock units and will be forfeited if those restricted stock units do not vest under the applicable award conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zaetta Christopher R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		89.629(1)	A	$0	16,716.169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)